G1 Therapeutics Q1 2024 GAAP EPS $(0.20), Inline, Sales $14.476M Miss $15.259M Estimate
G1 Therapeutics Q1 2024 GAAP EPS $(0.20), Inline, Sales $14.476M Miss $15.259M Estimate
G1 Therapeutics 2024年第一季度GAAP每股收益爲0.20美元（0.20美元），內聯，銷售額爲14476萬美元，低於預期的1525.9萬美元
G1 Therapeutics (NASDAQ:GTHX) reported quarterly losses of $(0.20) per share which met the analyst consensus estimate. This is a 62.26 percent increase over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $14.476 million which missed the analyst consensus estimate of $15.259 million by 5.13 percent. This is a 11.82 percent increase over sales of $12.946 million the same period last year.
G1 Therapeutics（納斯達克股票代碼：GTHX）公佈的季度虧損爲每股0.20美元，符合分析師的共識預期。這比去年同期每股虧損0.53美元（0.53）增長了62.26％。該公司公佈的季度銷售額爲14476萬美元，比分析師共識估計的1,525.9萬美元低5.13％。這比去年同期的1,294.6萬美元的銷售額增長了11.82％。